Page last updated: 2024-08-23

raloxifene hydrochloride and Embolism, Pulmonary

raloxifene hydrochloride has been researched along with Embolism, Pulmonary in 8 studies

Research

Studies (8)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (12.50)	18.2507
2000's	4 (50.00)	29.6817
2010's	3 (37.50)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Mosekilde, L; Pinholt, EM; Rejnmark, L; Schwartz, K; Vestergaard, P	1
Inoue, D	1
Clarfeld, RB; Costantino, JP; Grant, MD; McCaskill-Stevens, W; Vogel, VG; Wickerham, DL; Wolmark, N	1
Barrett-Connor, E; Cauley, JA; Cox, DA; Geiger, MJ; Kulkarni, PM; Sashegyi, A	1
Fallon, MA; Finkelstein, JS; Lee, H; Smith, MR	1
Adomaityte, J; Farooq, M; Qayyum, R	1
Beitz, J; Brinker, A	1

Reviews

3 review(s) available for raloxifene hydrochloride and Embolism, Pulmonary

Article	Year
[Effects of SERMs on bone health. Raloxifene effects on breast cancer and cardiovascular events]. Clinical calcium, 2010, Volume: 20, Issue:3 Topics: Arteriosclerosis; Breast Neoplasms; Female; Humans; Osteoporosis, Postmenopausal; Pulmonary Embolism; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Stroke; Venous Thrombosis	2010
Carcinoma in situ outcomes in National Surgical Adjuvant Breast and Bowel Project Breast Cancer Chemoprevention Trials. Journal of the National Cancer Institute. Monographs, 2010, Volume: 2010, Issue:41 Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Intraductal, Noninfiltrating; Carcinoma, Lobular; Chemoprevention; Clinical Trials as Topic; Endometrial Neoplasms; Female; Follow-Up Studies; Humans; Hyperplasia; Incidence; Multicenter Studies as Topic; Pulmonary Embolism; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Tamoxifen; Treatment Outcome	2010
Effect of raloxifene therapy on venous thromboembolism in postmenopausal women. A meta-analysis. Thrombosis and haemostasis, 2008, Volume: 99, Issue:2 Topics: Aged; Bone Density Conservation Agents; Female; Humans; Middle Aged; Odds Ratio; Osteoporosis, Postmenopausal; Patient Selection; Postmenopause; Pulmonary Embolism; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Selective Estrogen Receptor Modulators; Treatment Outcome; Venous Thromboembolism; Venous Thrombosis	2008

Trials

2 trial(s) available for raloxifene hydrochloride and Embolism, Pulmonary

Article	Year
Risk-benefit profile for raloxifene: 4-year data From the Multiple Outcomes of Raloxifene Evaluation (MORE) randomized trial. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2004, Volume: 19, Issue:8 Topics: Aged; Breast Neoplasms; Coronary Disease; Double-Blind Method; Female; Hip Fractures; Humans; Middle Aged; Osteoporosis, Postmenopausal; Proportional Hazards Models; Pulmonary Embolism; Raloxifene Hydrochloride; Risk Assessment; Stroke; Treatment Outcome	2004
Raloxifene to prevent gonadotropin-releasing hormone agonist-induced bone loss in men with prostate cancer: a randomized controlled trial. The Journal of clinical endocrinology and metabolism, 2004, Volume: 89, Issue:8 Topics: Aged; Biomarkers; Bone Density; Bone Remodeling; Double-Blind Method; Gonadotropin-Releasing Hormone; Humans; Male; Middle Aged; Osteoporosis; Prostatic Neoplasms; Pulmonary Embolism; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Testosterone	2004

Article

Year

Risk-benefit profile for raloxifene: 4-year data From the Multiple Outcomes of Raloxifene Evaluation (MORE) randomized trial.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2004, Volume: 19, Issue:8

Topics: Aged; Breast Neoplasms; Coronary Disease; Double-Blind Method; Female; Hip Fractures; Humans; Middle Aged; Osteoporosis, Postmenopausal; Proportional Hazards Models; Pulmonary Embolism; Raloxifene Hydrochloride; Risk Assessment; Stroke; Treatment Outcome

2004

Raloxifene to prevent gonadotropin-releasing hormone agonist-induced bone loss in men with prostate cancer: a randomized controlled trial.

The Journal of clinical endocrinology and metabolism, 2004, Volume: 89, Issue:8

Topics: Aged; Biomarkers; Bone Density; Bone Remodeling; Double-Blind Method; Gonadotropin-Releasing Hormone; Humans; Male; Middle Aged; Osteoporosis; Prostatic Neoplasms; Pulmonary Embolism; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Testosterone

2004

Other Studies

3 other study(ies) available for raloxifene hydrochloride and Embolism, Pulmonary

Article	Year
Use of bisphosphonates and raloxifene and risk of deep venous thromboembolism and pulmonary embolism. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2010, Volume: 21, Issue:9 Topics: Aged; Aged, 80 and over; Bone Density Conservation Agents; Denmark; Diphosphonates; Dose-Response Relationship, Drug; Epidemiologic Methods; Female; Humans; Male; Middle Aged; Organometallic Compounds; Osteoporosis; Pulmonary Embolism; Raloxifene Hydrochloride; Thiophenes; Venous Thromboembolism	2010
Tamoxifen for prevention of breast cancer. The Medical letter on drugs and therapeutics, 1999, Jan-01, Volume: 41, Issue:1043 Topics: Adult; Breast Neoplasms; Cerebrovascular Disorders; Drug Costs; Endometrial Neoplasms; Estrogen Antagonists; Estrogens; Female; Fractures, Bone; Humans; Middle Aged; Myocardial Infarction; Osteoporosis, Postmenopausal; Piperidines; Placebos; Pulmonary Embolism; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Tamoxifen; Thrombophlebitis	1999
Spontaneous reports of pulmonary embolism in association with raloxifene. Obstetrics and gynecology, 2001, Volume: 98, Issue:6 Topics: Adverse Drug Reaction Reporting Systems; Female; Humans; Osteoporosis, Postmenopausal; Pulmonary Embolism; Raloxifene Hydrochloride; Risk Factors; Selective Estrogen Receptor Modulators	2001